Misinformation from high-ranking health officials during the Trump administration has led to a significant “crisis of public trust,” prompting calls for Congress to conduct oversight hearings and potentially impeach figures like Robert F. Kennedy Jr., the head of the Department of Health and Human Services (HHS), as stated in a recently published report.
Experts have pointed out that in the past year, officials have closely examined issues surrounding vaccines and autism. They attempted to connect autism to acetaminophen (commonly known as Tylenol) use during pregnancy, despite accumulating evidence suggesting no link. Additionally, there were changes made to the federal autism committee, swapping out members for those with histories of anti-vaccine beliefs and pseudoscience.
The first meeting of the Interagency Autism Coordinating Committee (IACC) faced an unexpected postponement in March and was later rescheduled for a day that coincided with the release of a report by the Autistic Self Advocacy Network (ASAN) and the American Association of People with Disabilities (AAPD).
This report outlines various actions taken by HHS in the first year of the Trump administration, describing these moves as harmful to its mission and detrimental to the autistic community. These actions included layoffs, cuts in autism research funding by around $31 million, and the removal of warnings about unsafe autism treatments from the FDA’s website, commented Zoe Gross, director of advocacy at ASAN.
“Examining the sequence of events makes it clear just how difficult it has been for those of us advocating for autism,” Gross said, emphasizing the overwhelming nature of combating misinformation and harmful decisions. This flood of false information has been damaging to public health, she notes.
Shannon Rosa, cofounder of Thinking Person’s Guide to Autism, described the need for this kind of account as crucial. The incessant spread of misinformation feels overwhelming, making it harder for people in the autistic community to keep up. Having a documented timeline provides necessary tools to empower people to confront these issues within their communities.
Rosa pointed out the significance of tracking these actions promptly instead of waiting long periods for analysis. These points can serve as a foundation for discussions with local and state officials, enabling activists to advocate for change.
Recently, another statement by Kennedy sparked anger within the disability community. He suggested in budget hearings that home health aides might be defrauding the government, as some caregivers are being compensated for tasks they previously performed voluntarily. This assertion has ignited outrage among families, highlighting the vital role that paid caregivers play for disabled individuals who may not be able to work otherwise.
Last April, the timeline indicates several notable actions, such as issuing termination notices and closing the office that handled freedom of information requests, which hampered the transparency of health agencies. Kennedy had declared in a cabinet meeting that by September, they would uncover the causes of autism and labeled autism as “destroying families.” An acting director from the CDC also announced a new national autism registry.
This April, coinciding with Autism Acceptance Month, officials seem to be minimizing controversial decisions, perhaps in light of the upcoming midterm elections.
“RFK Jr. has toned down his rhetoric this April compared to last year,” noted Gross, adding that the HHS has also been quieter about their actions recently, such as postponing the IACC meeting.
However, Gross also mentioned, “I think RFK Jr. and his team remain committed to anti-vaccine initiatives.” The FDA had previously endorsed leucovorin, a B vitamin, as a treatment for autism and hinted at a connection between Tylenol use during pregnancy and autism in a September announcement. Nevertheless, the FDA has recently approved leucovorin solely for a rare folate deficiency, not for autism, and mounting research continues to discredit any link between autism and acetaminophen.
“They could have doubled down on leucovorin and acetaminophen, but there was a significant backlash,” Gross observed. It seems they may have recognized the negative response to these claims and are proceeding cautiously with the midterms approaching.
Still, they have not retracted their statements from September, which continue to perpetuate misinformation. Orders for Tylenol in emergency rooms dropped in the wake of the September announcement, leading to considerable uncertainty.
“Even though there’s been less public outcry, the core beliefs of HHS officials remain unchanged, and no one has indicated a shift in perspective,” Gross said.
According to an HHS spokesperson, the FDA is set to update safety labels for acetaminophen to include warnings about its potential effects during pregnancy.
“We’d really like Congress to hold RFK Jr. and the HHS accountable for their actions this past year, which have harmed both the autistic community and public health,” Gross stated. “If there’s sufficient evidence during those hearings showing that RFK Jr. has been neglectful in his duties, impeachment should be on the table.”
